Search

everythinglearnresearchcommunity

for

Search:↓

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Topical JAK inhibitors may help treat some skin conditions but need more research.

The electronic version of the Dermatology Life Quality Index is as effective as the paper version, with most patients preferring it.

Genes controlling hair growth and immune response are disrupted in male pattern baldness.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Air pollution worsens skin diseases and aging by causing inflammation and oxidative stress.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Bee venom might be a good alternative treatment for various skin conditions because it has many healing properties.

Effective treatment for hidradenitis suppurativa varies, with antibiotics commonly used and surgery as an option, but no single method is universally successful.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Apremilast shows promise for several skin conditions but needs more research.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Low-level laser therapy may help with hair regrowth in alopecia areata but its effectiveness for psoriasis and atopic dermatitis needs more research.

Smoking and certain health conditions like thyroid disease may make palmoplantar pustulosis harder to treat.

Severe Hidradenitis Suppurativa increases missed and unproductive workdays.

Different staff in a dermatology clinic understand mostly their own tasks, not the full clinic process.

Female authorship in dermatology publications increased during the COVID-19 pandemic, but women are still underrepresented in senior roles.

Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Platelet-rich plasma treatment may safely and effectively reduce skin lesions in psoriasis and atopic dermatitis.

Mineral levels in hair don't significantly affect the severity of atopic dermatitis in children.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Soy supplements improve various skin conditions and aging signs, with topical use boosting skin barrier function.